First Light Asset Management as of Dec. 31, 2014
Portfolio Holdings for First Light Asset Management
First Light Asset Management holds 66 positions in its portfolio as reported in the December 2014 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| AtriCure (ATRC) | 7.2 | $13M | 636k | 19.96 | |
| NeoGenomics (NEO) | 6.3 | $11M | 2.7M | 4.17 | |
| Spectranetics Corporation | 6.1 | $11M | 312k | 34.58 | |
| Akorn | 4.8 | $8.4M | 233k | 36.20 | |
| Harvard Bioscience (HBIO) | 4.5 | $8.0M | 1.4M | 5.67 | |
| RTI Biologics | 4.2 | $7.4M | 1.4M | 5.20 | |
| NxStage Medical | 3.8 | $6.7M | 373k | 17.93 | |
| IGI Laboratories | 3.7 | $6.5M | 735k | 8.80 | |
| Enzo Biochem (ENZ) | 3.0 | $5.4M | 1.2M | 4.44 | |
| Array BioPharma | 3.0 | $5.3M | 1.1M | 4.73 | |
| Ligand Pharmaceuticals In (LGND) | 2.5 | $4.4M | 82k | 53.21 | |
| Quidel Corporation | 2.4 | $4.1M | 143k | 28.92 | |
| Alkermes (ALKS) | 2.4 | $4.2M | 71k | 58.57 | |
| Omnicell (OMCL) | 2.3 | $4.0M | 121k | 33.12 | |
| Streamline Health Solutions (STRM) | 2.2 | $3.9M | 904k | 4.33 | |
| Endologix | 2.2 | $3.8M | 250k | 15.29 | |
| Veracyte (VCYT) | 2.2 | $3.8M | 394k | 9.66 | |
| Oxford Immunotec Global | 2.1 | $3.7M | 274k | 13.62 | |
| AngioDynamics (ANGO) | 2.1 | $3.7M | 195k | 19.01 | |
| Novadaq Technologies | 2.1 | $3.7M | 223k | 16.62 | |
| Bio-techne Corporation (TECH) | 2.0 | $3.6M | 39k | 92.40 | |
| Vanda Pharmaceuticals (VNDA) | 1.9 | $3.3M | 230k | 14.32 | |
| Celldex Therapeutics | 1.6 | $2.8M | 154k | 18.25 | |
| STAAR Surgical Company (STAA) | 1.6 | $2.8M | 306k | 9.11 | |
| D Fluidigm Corp Del (LAB) | 1.5 | $2.7M | 81k | 33.73 | |
| Tearlab Corp | 1.4 | $2.5M | 953k | 2.65 | |
| HealthStream (HSTM) | 1.4 | $2.4M | 82k | 29.47 | |
| Cepheid | 1.4 | $2.4M | 45k | 54.14 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 1.2 | $2.1M | 18k | 118.81 | |
| Align Technology (ALGN) | 1.2 | $2.1M | 37k | 55.91 | |
| LeMaitre Vascular (LMAT) | 1.1 | $2.0M | 263k | 7.65 | |
| BioMarin Pharmaceutical (BMRN) | 1.1 | $2.0M | 22k | 90.38 | |
| Salix Pharmaceuticals | 1.1 | $2.0M | 17k | 114.92 | |
| Lannett Company | 1.1 | $2.0M | 46k | 42.87 | |
| ISIS Pharmaceuticals | 1.0 | $1.8M | 30k | 61.75 | |
| Sunopta (STKL) | 0.9 | $1.6M | 133k | 11.85 | |
| Bluebird Bio (BLUE) | 0.8 | $1.5M | 16k | 91.70 | |
| Cytokinetics (CYTK) | 0.8 | $1.4M | 179k | 8.01 | |
| Spectrum Pharmaceuticals | 0.7 | $1.3M | 188k | 6.93 | |
| Sagent Pharmaceuticals | 0.6 | $1.1M | 43k | 25.12 | |
| Aratana Therapeutics | 0.6 | $1.0M | 58k | 17.82 | |
| Endo International (ENDPQ) | 0.3 | $589k | 8.2k | 72.17 | |
| Novartis (NVS) | 0.3 | $562k | 6.1k | 92.59 | |
| Mylan | 0.3 | $551k | 9.8k | 56.37 | |
| Actavis | 0.3 | $524k | 2.0k | 257.49 | |
| Humana (HUM) | 0.3 | $508k | 3.5k | 143.50 | |
| Anthem (ELV) | 0.3 | $515k | 4.1k | 125.76 | |
| Bristol Myers Squibb (BMY) | 0.3 | $489k | 8.3k | 58.99 | |
| United Therapeutics Corporation (UTHR) | 0.3 | $495k | 3.8k | 129.58 | |
| Celgene Corporation | 0.3 | $479k | 4.3k | 111.92 | |
| Aetna | 0.3 | $463k | 5.2k | 88.78 | |
| CareFusion Corporation | 0.3 | $459k | 7.7k | 59.38 | |
| Johnson & Johnson (JNJ) | 0.2 | $399k | 3.8k | 104.45 | |
| Steris Corporation | 0.2 | $411k | 6.3k | 64.93 | |
| AstraZeneca (AZN) | 0.2 | $400k | 5.7k | 70.42 | |
| Becton, Dickinson and (BDX) | 0.2 | $389k | 2.8k | 139.18 | |
| St. Jude Medical | 0.2 | $394k | 6.1k | 65.07 | |
| Eli Lilly & Co. (LLY) | 0.2 | $379k | 5.5k | 68.97 | |
| Amgen (AMGN) | 0.2 | $371k | 2.3k | 159.23 | |
| Merck & Co (MRK) | 0.2 | $375k | 6.6k | 56.73 | |
| Pfizer (PFE) | 0.2 | $328k | 11k | 31.18 | |
| Community Health Systems (CYH) | 0.2 | $331k | 6.1k | 53.86 | |
| Sanofi-Aventis SA (SNY) | 0.1 | $259k | 5.7k | 45.60 | |
| Myriad Genetics (MYGN) | 0.1 | $266k | 7.8k | 34.02 | |
| Agilent Technologies Inc C ommon (A) | 0.1 | $210k | 5.1k | 41.02 | |
| Bio-Rad Laboratories (BIO) | 0.1 | $202k | 1.7k | 120.60 |
